Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$12.42 - $15.62 $683 - $859
55 Added 0.45%
12,375 $193,000
Q3 2022

Nov 10, 2022

SELL
$12.8 - $28.65 $5,734 - $12,835
-448 Reduced 3.51%
12,320 $160,000
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $304,121 - $344,776
-22,461 Reduced 63.76%
12,768 $183,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $316,106 - $393,632
-24,002 Reduced 40.52%
35,229 $480,000
Q3 2021

Nov 12, 2021

SELL
$16.3 - $17.26 $449,325 - $475,789
-27,566 Reduced 31.76%
59,231 $970,000
Q2 2021

Aug 16, 2021

BUY
$16.55 - $18.64 $1.07 Million - $1.21 Million
64,951 Added 297.31%
86,797 $1.46 Million
Q1 2021

May 14, 2021

SELL
$16.71 - $19.9 $309,485 - $368,567
-18,521 Reduced 45.88%
21,846 $399,000
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $2.1 Million - $2.59 Million
-136,323 Reduced 77.15%
40,367 $735,000
Q3 2020

Nov 13, 2020

SELL
$17.1 - $19.19 $5.51 Million - $6.18 Million
-322,074 Reduced 64.57%
176,690 $3.15 Million
Q2 2020

Aug 12, 2020

BUY
$14.59 - $19.5 $6.17 Million - $8.25 Million
423,166 Added 559.76%
498,764 $8.94 Million
Q1 2020

May 13, 2020

SELL
$13.02 - $20.31 $1.32 Million - $2.06 Million
-101,223 Reduced 57.25%
75,598 $1.15 Million
Q4 2019

Feb 12, 2020

BUY
$16.88 - $20.83 $755,346 - $932,100
44,748 Added 33.88%
176,821 $3.49 Million
Q3 2019

Nov 12, 2019

SELL
$16.15 - $17.99 $5.52 Million - $6.15 Million
-341,690 Reduced 72.12%
132,073 $2.27 Million
Q2 2019

Aug 14, 2019

BUY
$16.58 - $20.49 $4.54 Million - $5.61 Million
273,855 Added 136.99%
473,763 $8.39 Million
Q1 2019

May 14, 2019

SELL
$16.7 - $21.52 $19.5 Million - $25.1 Million
-1,167,972 Reduced 85.39%
199,908 $4.07 Million
Q4 2018

Feb 13, 2019

BUY
$15.64 - $21.1 $21.4 Million - $28.9 Million
1,367,880 New
1,367,880 $23 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.